Efficacy and Safety of Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura in Children and Adolescents - Egyptian Knowledge Bank - troweb

49264

Efficacy and Safety of Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura in Children and Adolescents

Article

Last updated: 30 Jan 2023

Overview Similar Items

Article

RETROSPECTIVE EVALUATION OF THE OUTCOME OF IMMUNE THROMBOCYTOPENIA IN CHILDREN AND ADOLESCENTS: SINGLE CENTER EXPERIENCE

Article

STUDY OF INTERLEUKIN-33 IN IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDREN

Article

Study of The Role of Antiplatelet Antibodies in Children with Immune Thrombocytopenic Purpura

Article

Assessment of T-Regulatory Cell in Children with Chronic Immune Thrombocytopenia

Article

Platelet apoptosis in pediatric immune thrombocytopenia

Article

Study of Clinical Features and Laboratory Findings in Children with Immune Thrombocytopenia

Article

New Aspects in Pathogenesis of Primary Immune Thrombocytopenia In Pediatric Patients

Article

Role of Eltrompobag in treatment of thrombocytopenia associated with chronic Hepatitis C Virus

Article

Prognostic Clinical and Laboratory Parameters in Children with primary Immune Thrombocytopenic Purpura

Article

The Role of Helicobacter Pylori Infection in Idiopathic Thrombocytopenic Purpura in Children